We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIVN icon
1901
LivaNova
LIVN
$4.4B
$3.93M ﹤0.01%
53,320
+4,392
+9% +$338K
JKS
1902
JinkoSolar
JKS
$793M
$3.93M ﹤0.01%
246,401
+72,860
+42% +$1.46M
STL
1903
DELISTED
Sterling Bancorp
STL
$3.93M ﹤0.01%
195,770
-6,604
-3% -$134K
BID
1904
DELISTED
Sotheby's
BID
$3.92M ﹤0.01%
68,852
-18,831
-21% -$1.09M
LBTYA icon
1905
Liberty Global Class A
LBTYA
$3.62B
$3.92M ﹤0.01%
158,326
+12,935
+9% +$345K
FCFS icon
1906
FirstCash
FCFS
$8.85B
$3.9M ﹤0.01%
42,586
+3,355
+9% +$333K
ADNT icon
1907
Adient
ADNT
$1.65B
$3.9M ﹤0.01%
169,849
+93,925
+124% +$2.14M
ICUI icon
1908
ICU Medical
ICUI
$4.21B
$3.9M ﹤0.01%
24,415
+9,956
+69% +$1.98M
REML
1909
DELISTED
Credit Suisse X-Links Monthly Pay 2xLeveraged Mortgage REIT ETN
REML
$3.88M ﹤0.01%
168,627
KMPR icon
1910
Kemper
KMPR
$1.67B
$3.88M ﹤0.01%
49,749
-14,856
-23% -$1.19M
IBKC
1911
DELISTED
IBERIABANK Corp
IBKC
$3.87M ﹤0.01%
51,200
+11,034
+27% +$814K
TXNM
1912
TXNM Energy Inc
TXNM
$6.41B
$3.87M ﹤0.01%
74,205
+10,914
+17% +$551K
SITC icon
1913
SITE Centers
SITC
$225M
$3.86M ﹤0.01%
327,076
-28,787
-8% -$314K
UTHR icon
1914
United Therapeutics
UTHR
$25.8B
$3.85M ﹤0.01%
48,350
-5,774
-11% -$465K
WSM icon
1915
Williams-Sonoma
WSM
$26.9B
$3.84M ﹤0.01%
113,094
-107,712
-49% -$3.57M
RARE icon
1916
Ultragenyx Pharmaceutical
RARE
$2.45B
$3.83M ﹤0.01%
89,504
+44,777
+100% +$2.43M
FCPT icon
1917
Four Corners Property Trust
FCPT
$2.81B
$3.83M ﹤0.01%
135,335
-54,035
-29% -$1.51M
CELH icon
1918
Celsius Holdings
CELH
$7.47B
$3.82M ﹤0.01%
3,294,822
-140,544
-4% -$196K
VET icon
1919
Vermilion Energy
VET
$1.82B
$3.82M ﹤0.01%
228,460
-133,453
-37% -$2.32M
IOTS
1920
DELISTED
Adesto Technologies Corp
IOTS
$3.81M ﹤0.01%
445,121
+434,389
+4,048% +$4.05M
AN icon
1921
CALL
AutoNation
AN
$7.11B
$3.8M ﹤0.01%
+75,000
New +$3.53M
TNET icon
1922
TriNet
TNET
$3.02B
$3.8M ﹤0.01%
61,115
+20,629
+51% +$1.41M
MRVL icon
1923
CALL
Marvell Technology
MRVL
$168B
$3.8M ﹤0.01%
+152,100
New +$3.82M
ACIC icon
1924
American Coastal Insurance
ACIC
$515M
$3.79M ﹤0.01%
271,265
+17,909
+7% +$231K
VRTX icon
1925
CALL
Vertex Pharmaceuticals
VRTX
$121B
$3.79M ﹤0.01%
22,400
+1,600
+8% +$283K

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.